Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 20 of 68 for “"PON1"”.
-
Neurological profile of older ApoE-PON1 double knockout mice
… in Alzheimer's pathology. Serum paraoxonase 1 (PON1) is a lipoprotein associated antioxidant enzyme that prevents lipid peroxidation. S100B protein is a plasma biomarker, altered expression of which has been implied in AD. We propose the hypothesis that combined deficiencies in apolipoprotein E …
-
Paraoxonase (PON1) polymorphisms as a biomarker of susceptibility to organophosphate toxicity among a cohort of Singaporean workers
… inhibition. The enzyme human serum paraoxonase (PON1) is involved in detoxification of OP compounds. PON1 polymorphisms have been shown to affect susceptibility to OP exposure. Here, we investigated the effect of OP exposure on pest control workers and assessed the distribution of two common PON1 …
-
Lipids and cognition in Chinese older adults: Investigating APOE, PON1, N-3 PUFA in the Singapore Longitudinal Aging studies
… studies to examine the relationship of APOE e4, PON1 gene polymorphism, n-3 PUFA and cognition in elderly Chinese Singaporeans who were recruited from two sources: (1) patients with confirmed dementia diagnosis from Alexandra Hospital and (2) participants in the Singapore Longitudinal Ageing …
-
Paraoxonase and cardiovascular disease: actions and interactions.
Paraoxonase type 1 (PON1) is an enzyme which belongs to the family of paraoxonases. Other members of the paraoxonase family are PON2 and PON3. In the human body, PON1 is located exclusively on the high-density lipoprotein (HDL) particle. As the name 'paraoxonase' indicates, PON1 can hydrolyze the …
-
Association of Pyrethroid and Chlorpyrifos Exposure and PON1 Genotype with Oxidative Stress marker (F2-Isoprostane) in Adolescents from Montevideo, Uruguay
… as the Q192R polymorphism in the Paraoxonase-1 (PON1) gene, may further influence individual susceptibility to pesticide-related oxidative damage, yet studies exploring this relationship remain limited. OBJECTIVE: This study investigated the association between urinary concentrations of …
-
Phytoremediation of Chlorpyrifos Insecticide: The Use of Woody Plants and Transgenics to Enhance and Understand the Uptake, Translocation, and Transformation of Chlorpyrifos
… were developed. Transgenic poplar plants (`PON1-34') expressing rabbit pon1 gene, which is known to be involved in OP insecticide degradation pathways, were produced and investigated for increased tolerance and removal of CPS. However, there was no change in phytotoxicity of CPS or uptake of …
-
Paraxonase-1 Variants Alter Stability and Activity
Paraoxonase-1 (PON1) is a high-density lipoprotein-associated enzyme that has been extensively studied due to its ability to hydrolyze and inactivate toxic compounds such as organophosphate (OP) pesticide metabolites and its anti-atherogenic properties. However, the physiological substrate of PON1 …
-
Επίδραση του πλούσιου σε πολυφαινολικά συστατικά εκχυλίσματος κορινθιακής σταφίδας στην έκφραση και τη δραστικότητα του αντιοξειδωτικού ενζύμου Παραοξονάση 1 (PON1): Σχέση με τη νόσο ALZHEIMER
Το ένζυμο παραοξονάση 1 (PON1), που συντίθεται στο ήπαρ και απελευθερώνεται στην κυκλοφορία, έχει αντιοξειδωτική δράση. Επιδημιολογικές μελέτες έχουν δείξει ότι μειωμένη δραστικότητα της PON1 στον ορό σχετίζεται με τη νόσο Alzheimer (AD). Η AD είναι μία σταδιακά καταστροφική και μη αναστρέψιμη …
-
Ο ρόλος των ενζύμων που σχετίζονται με τις HDL στην πρόληψη της καρδιαγγειακής νόσου
… activity, PAF-AH itself and paraoxonase-1 (PON1). The relative contribution of these enzymes in the expression of PAF-AH activity on HDL remains to be established. We investigated whether the PON1 polymorphisms (M55L and Q192R) or the PAF-AH polymorphism V379A could affect the PAF-AH …
-
Γενετική μελέτη ασθενών με απόφραξη φλέβας αμφιβληστροειδούς
… genes [apolipoprotein E (APOE), paraoxonase 1 (PON1) and stromal cell-derived factor 1 (SDF-1)] and the risk of RVO in a Greek population. Another purpose of this study was to determine whether these specific genetic polymorphisms affect the response to intravitreal anti-vascular endothelial …
-
Einfluss des Paraoxonase-Phänotyps auf die Abbaugeschwindigkeit hochtoxischer Phosphoryloxime
… wurden durch humane Paraoxonase 1 (PON1) hydrolysiert, dabei war das Alloenzym PON1 192Q um den Faktor 50 aktiver als PON1 192R. Das Verhältnis der Hydrolysegeschwindigkeiten mit Obidoxime als Produkt war 1:6:0,03 für die jeweiligen POX-Verbindungen. Die Geschwindigkeit des …
-
Isolierung, Identifizierung und Inhibition von Esterasen aus Ratten- und Hundeserum zur Stabilisierung von Serumproben ex vivo im Rahmen der präklinischen Arzneimittelentwicklung
… die spaltenden Esterasen (wahrscheinlich PON1) in hoher Ausbeute aus Rattenserum isoliert. Die Drospirenon-spaltenden Esterasen in Hundeserum wurden mittels PON-AC gereinigt, allerdings nur mit geringer Ausbeute und Anreicherung. Die dreistufige Reinigung war für die Isolierung …
-
Atheroprotective targets associated with high-density lipoprotein: phospholipid transfer protein, paraoxonase-1, and their effects on cerebrovascular disease
… transfer protein (PLTP) and paraoxonase-1 (PON1). First, I demonstrate that commercially available assays of PLTP activity are only weakly correlated with the low-throughput, but gold-standard radiometric PLTP assay. Using a large collection of participants with radiometrically-measured PLTP …
-
Interactions between anthocyanins, cholesterol metabolism and PON-1 in relation to HDL quality and CVD risk
… and enzyme activities of paraoxonase-1 (PON1) (marker of HDL function) were tested at physiologically relevant concentrations. The effects of anthocyanin consumption on cholesterol efflux transporters was investigated by quantifying the expression of ABCA1 and ABCG1 in aortic and liver …
-
Efeitos do extrato de Pu Erh (Camellia sinensis) no metabolismo intermediário e na atividade da paraoxonase 1 em ratos alimentados com dieta hiperlipídica
… (DCV) e dislipidemias. A paraoxonase 1 (PON1) plasmática é uma enzima produzida no fígado e liberada para a circulação junto com a lipoproteínas de alta densidade (HDL). Quanto menor a atividade da PON1, maior o nível de triacilgliceróis (TGC) e lipoproteínas de baixa densidade (LDL) e …
-
Μελέτη της σύστασης και της λειτουργίας της λιποπρωτεΐνης υψηλής πυκνότητας (HDL) σε παθολογικές καταστάσεις, καθώς και της ενίσχυσης των αθηροπροστατευτικών λειτουργιών της HDL με μικρά μόρια
… of the antioxidant enzyme paraoxonase 1 (PON1), which is associated with HDL and is involved in its atheroprotective functions, was examined. Reductions in PON1 activity have been observed in patients with RA and have been associated with an increased risk of CVD. Screening analyses …
-
Alterações no metabolismo lipídico em pacientes HIV soropositivos
… podem ser mediadas pela ação da paraoxonase 1 (PON1). Esta enzima está, predominantemente, associada com a HDL e catalisa a degradação de fosfolípides provenientes da LDL oxidada. Outras ações antiaterogênicas da HDL são: sua propriedade antitrombótica, antioxidante, antiinflamatória e …
-
Ποσοτικές και ποιοτικές διαταραχές των λιπιδίων σε ασθενείς με οξείες λοιμώξεις
… ester transfer protein (CETP), paraoxonase 1 (PON1) and lipoprotein-associated phospholipase A2 (Lp-PLA2) as well as levels of cytokines [interleukins (IL)-1β, IL-6 and tumor necrosis factor (TNFa)] were also determined. Low-density lipoprotein (LDL) subclass analysis was performed with the …
-
IDENTIFICAZIONE DI BIOMARCATORI PER LA DIAGNOSI PRECOCE DEL TUMORE POLMONARE
… systemic (Serum Amyloid A, SAA; Paraoxinase 1, PON1; and 50 plasmatic cytokines) and local (proteins and metabolites in exhaled breath condensate, EBC) inflammation and oxidative stress. We also studied the relationships between these parameters and the pulmonary function measured as FEV1 …
-
The pharmacogenomics of vincristine-induced neurotoxicity in paediatric cancer patients with Wilms tumor or rhabdomyosarcoma
… sizes, six novel genetic variants in five genes (PON1, ABCA4, ABCG1, CY51A1, SLCO1C1) were significantly associated with VIN in both tumor types. Whereas none of these genes have been previously associated with VIN or the biotransformation of vincristine, interestingly,the biological functions of …
Page 1 of 4